ARS Pharmaceuticals, Inc.(NasdaqGM:SPRY) dropped from Russell 3000E Value Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.33 USD | -0.09% |
|
+8.32% | +106.75% |
11/07 | Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing | MT |
11/07 | Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+106.75% | 109.88Cr | |
+24.74% | 4.8TCr | |
-0.47% | 4.24TCr | |
+43.96% | 4.15TCr | |
+25.40% | 3.16TCr | |
+17.96% | 2.86TCr | |
-4.47% | 2.8TCr | |
+50.73% | 1.46TCr | |
+42.56% | 1.41TCr | |
+1.46% | 1.26TCr |
- Stock Market
- Equities
- SPRY Stock
- News ARS Pharmaceuticals, Inc.
- ARS Pharmaceuticals, Inc.(NasdaqGM: SPRY) dropped from Russell 3000E Value Index